References
- Nadel S, Ninis N. Invasive meningococcal disease in the vaccine Era. Front Pediatr. 2018;6:321. doi:10.3389/fped.2018.00321.
- Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(12):853–10. doi:10.1016/S1473-3099(10)70251-6.
- European Centre for Disease Prevention and Control. Factsheet about meningococcal disease. European Centre For Disease Prevention And Control; 2019 [accessed 2023 Dec 5]. https://www.ecdc.europa.eu/en/meningococcal.disease/factsheet.
- Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30(Suppl 2):B3–9. doi:10.1016/j.vaccine.2011.12.062.
- European Centre for Disease Prevention and Control. Invasive meningococcal disease annual epidemiological report for 2017. Stockholm: European Centre for Disease Prevention and Control; 2019 [accessed 2023 Dec 5]. https://www.ecdc.europa.eu/sites/default/files/documents/AERfor2017-invasive-meningococcal-disease.pdf.
- Krone M, Gray S, Abad R, Skoczyńska A, Stefanelli P, van der Ende A, Tzanakaki G, Mölling P, João Simões M, Křížová P, et al. Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017. Eur Surveill. 2019;24:1800245. doi:10.2807/1560-7917.ES.2019.24.14.1800245.
- Whittaker R, Dias JG, Ramliden M, Ködmön C, Economopoulou A, Beer N, Pastore Celentano L. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004–2014. Vaccine. 2017;35:2034–41. doi:10.1016/j.vaccine.2017.03.007.
- Nuttens C, Findlow J, Balmer P, Swerdlow DL. Tin Tin Htar M. evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017. Eur Surveill. 2022;27:2002075. doi:10.2807/1560-7917.ES.2022.27.3.2002075.
- Larrauri A, Cano R, García M, de Mateo S. Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain. Vaccine. 2005;23(32):4097–100. doi:10.1016/j.vaccine.2005.03.045.
- Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet Child Adolesc Health. 2004;364:365–7. doi:10.1016/S0140-6736(04)16725-1.
- Vuocolo S, Balmer P, Gruber WC, Jansen KU, Anderson AS, Perez JL, York LJ. Vaccination strategies for the prevention of meningococcal disease. Hum Vaccin Immunother. 2018;14(5):1203–15. doi:10.1080/21645515.2018.1451287.
- Mbaeyi S, Pondo T, Blain A, Yankey D, Potts C, Cohn A, Hariri S, Shang N, MacNeil JR. Incidence of meningococcal disease before and after implementation of quadrivalent meningococcal conjugate vaccine in the United States. JAMA Pediatr. 2020;174(9):843–51. doi:10.1001/jamapediatrics.2020.1990.
- Campbell H, Andrews N, Parikh SR, White J, Edelstein M, Bai X, Lucidarme J, Borrow R, Ramsay ME, Ladhani SN. Impact of an adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: a national surveillance and modelling study. Lancet Child Adolesc Health. 2022;6:96–105. doi:10.1016/S2352-4642(21)00335-7.
- Kafetzis DA, Stamboulidis KN, Tzanakaki G, Kremastinou JK, Skevaki CL, Konstantopoulos A, Tsolia M. Meningococcal group C disease in Greece during 1993–2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians. Clin Microbiol Infect. 2007;13(5):550–2. doi:10.1111/j.1469-0691.2007.01704.x.
- Ladomenou F, Tzanakaki G, Kolyva S, Katsarakis I, Maraki S, Galanakis E. Conjugate vaccines dramatically reshaped the epidemiology of bacterial meningitis in a well-defined child population. Acta Paediatr. 2020;109(2):368–74. doi:10.1111/apa.14957.
- Martinón-Torres F, Taha M-K, Knuf M, Abbing-Karahagopian V, Pellegrini M, Bekkat-Berkani R, Abitbol V. Evolving strategies for meningococcal vaccination in Europe: overview and key determinants for current and future considerations. Pathog Global Health. 2022;116:85–98. doi:10.1080/20477724.2021.1972663.
- Pizza M, Bekkat-Berkani R, Rappuoli R. Vaccines against meningococcal diseases. Microorganisms. 2020;8(10):1521. doi:10.3390/microorganisms8101521.
- Bröker M, Berti F, Costantino P. Factors contributing to the immunogenicity of meningococcal conjugate vaccines. Hum Vaccines Immunother. 2016;12:1808–24. doi:10.1080/21645515.2016.1153206.
- Croatian Institute of Public Health. Croatian health and statistical yearbook for 2019. 2019 [accessed 2022 May 6]. https://www.hzjz.hr/hrvatski-zdravstveno-statisticki-ljetopis/hrvatski-zdravstveno-statisticki-ljetopis-za-2019/.
- Institute for Public Health of Serbia. Health and statistical yearbook of the republic of Serbia. 2020 [ accessed 2022 May 6]. https://www.batut.org.rs/index.php?content=77.
- Public Health Center of the Ministry of Health of Ukraine. Infectious disease in the population of Ukraine. 2022 [accessed 2022 May 6]. https://phc.org.ua/kontrol-zakhvoryuvan/inshi-infekciyni-zakhvoryuvannya/infekciyna-zakhvoryuvanist-naselennya-ukraini.
- National Institute of Public Health National Center for Surveillance and Control of Communicable Diseases. Analysis of the evolution of communicable diseases under surveillance. 2018 [accessed 2022 May 6]. http://www.cnscbt.ro/index.php/rapoarte-anuale/1302-analiza-bolilor-transmisibile-aflate-in-supraveghere-raport-pentru-anul-2018/file.
- Koroun National Reference Center for the Diagnostics of Bacterial Infections of the Central Nervous System. Epidemiological data. 2021 [accessed 2023 May 12]. http://koroun.nil.gov.pl/dane-epidemiologiczne/.
- Krizova P, Honskus M, Okonji Z, Musilek M, Kozakova J. Analysis of epidemiological and molecular data from invasive meningococcal disease surveillance in the Czech Republic, 1993–2020. Epidemiol Mikrobiol Imunol. 2022;71:148–60.
- National Center of Surveillance and Control of Infectious Diseases. Sistem de supraveghere si control in boala meningococica. 2016 [accessed 2023 February 17]. https://www.cnscbt.ro/index.php/metodologii/boala-meningococica/479-metodologie-supraveghere-boala-meningococica/file
- European Centre for Disease Prevention and Control. Surveillance atlas of infectious diseases. Stockholm; 2022 [accessed 2022 May 31]. https://atlas.ecdc.europa.eu/public/index.aspx.
- European Centre for Disease Prevention and Control. EU Case Definitions. 2023 [accessed 2023 May 12]. https://www.ecdc.europa.eu/en/all-topics/eu-case-definitions.
- World Health Organization. Invasive meningococcal outbreak toolbox. 2022 [accessed 2023 December 5]. https://www.who.int/emergencies/outbreak-toolkit/disease-outbreak-toolboxes/invasive-meningoccocal-outbreak-toolbox.
- World Health Organization. European health information gateway. 2023 [accessed 2023 June 1]. https://gateway.euro.who.int/en/hfa-explorer/#ViBHUF2xyX.
- National Center of Surveillance and Control of Infectious Diseases. Analiza evolutiei bolilor transmisibile aflate in supraveghere, Raport pentru anul 2012. 2012 [accessed 2023 February 17]. https://www.cnscbt.ro/index.php/rapoarte-anuale/546-analiza-evolutiei-bolilor-transmisibile-aflate-in-supraveghere-raport-pentru-anul-2012.
- Diseases NCoSaCoI. Analiza evolutiei bolilor transmisibile aflate in supraveghere, Raport pentru anul 2014. 2014 [accessed 2023 February 17]. https://www.cnscbt.ro/index.php/rapoarte-anuale/548-analiza-evolutiei-bolilor-transmisibile-aflate-in-supraveghere-raport-pentru-anul-2014.
- Diseases NCoSaCoI. Analiza evolutiei bolilor transmisibile aflate in supraveghere, Raport pentru anul 2015. 2015 [accessed 2023 February 17]. https://www.cnscbt.ro/index.php/rapoarte-anuale/549-analiza-evolutiei-bolilor-transmisibile-aflate-in-supraveghere-raport-pentru-anul-2015.
- Azoicăi D, Rădulescu A, Pițigoi D, Popovici F. Recomandări de vaccinare a pacienților cu imunodeficiențe de diverse cauze. Editie revizuita si adaugita. Ed. 2. 2020 [accessed 2023 December 5]. https://lege5.ro/gratuit/gyzdcnbugm4q/ghidul-recomandari-de-vaccinare-a-pacientilor-cu-imunodeficiente-de-diverse-cauze-din-05042021.
- Gómez JA, Wetzler Malbrán P, Vidal G, Seoane M, Giglio ND. Estimation of the real burden of invasive meningococcal disease in Argentina. Epidemiol Infect. 2019;147:e311–e. doi:10.1017/S0950268819002024.
- Gilbert R, Cliffe SJ. Public health surveillance. Public Health Intelligence. 2016; 27:91–110.
- Azzari C, Nieddu F, Moriondo M, Indolfi G, Canessa C, Ricci S, Bianchi L, Serranti D, Poggi GM, Resti M. Underestimation of invasive meningococcal disease in Italy. Emerg Infect Dis. 2016;22(3):469–75. doi:10.3201/eid2203.150928.
- Peterson ME, Li Y, Bita A, Moureau A, Nair H, Kyaw MH, Abad R, Bailey F, Garcia IF, Decheva A, et al. Meningococcal serogroups and surveillance: a systematic review and survey. J Glob Health. 2019;9:010409. doi:10.7189/jogh.09.010409.
- Flountzi A, Georgakopoulou T, Balasegaram S, Kesanopoulos K, Xirogianni A, Papandreou A, Tzanakaki G, Anastasia A, Athina A, Genovefa C, et al. Epidemiology of invasive meningococcal disease in Greece, 2006–2016. Eur J Clin Microbiol Infect Dis. 2019;38:2197–203. doi:10.1007/s10096-019-03668-y.
- Jandova Z, Musilek M, Vackova Z, Kozakova J, Krizova P, Hozbor DF. Serogroup and clonal characterization of Czech invasive Neisseria meningitidis strains isolated from 1971 to 2015. PLoS One. 2016;11(12):e0167762. doi:10.1371/journal.pone.0167762.
- Luca V, Gessner BD, Luca C, Turcu T, Rugina S, Rugina C, Ilie M, Novakova E, Vlasich C. Incidence and etiological agents of bacterial meningitis among children <5 years of age in two districts of Romania. Eur J Clin Microbiol Infect Dis. 2004;23:523–8. doi:10.1007/s10096-004-1169-6.
- Pinto Cardoso G, Lagree-Chastan M, Caseris M, Gaudelus J, Haas H, Leroy JP, Bakhache P, Pujol JF, Werner A, Dommergues MA, et al. Overview of meningococcal epidemiology and national immunization programs in children and adolescents in 8 Western European countries. Front Pediatr. 2022;10:1000657. doi:10.3389/fped.2022.1000657.
- Bai X, Borrow R, Bukovski S, Caugant DA, Culic D, Delic S, Dinleyici EC, Eloshvili M, Erdősi T, Galajeva J, et al. Prevention and control of meningococcal disease: updates from the global meningococcal initiative in Eastern Europe. J Infect. 2019;79(6):528–41. doi:10.1016/j.jinf.2019.10.018.
- Ladhani SN, Andrews N, Parikh SR, Campbell H, White J, Edelstein M, Bai X, Lucidarme J, Borrow R, Ramsay ME. Vaccination of infants with meningococcal group B vaccine (4CMenB) in England. N Engl J Med. 2020;382(4):309–17. doi:10.1056/NEJMoa1901229.
- Tsolia MN, Theodoridou M, Tzanakaki G, Vlachou V, Mostrou G, Stripeli F, Kalabalikis P, Pangalis A, Kafetzis D, Kremastinou J. et al. Invasive meningococcal disease in children in Greece: comparison of serogroup a disease with disease caused by other serogroups. Eur J Clin Microbiol Infect Dis. 2006;25(7):449–56. doi:10.1007/s10096-006-0155-6.
- Kremastinou J, Tzanakaki G, Velonakis E, Voyiatzi A, Nickolaou A, Elton RA, Weir D, Blackwell C. Carriage of Neisseria meningitidis and Neisseria lactamica among ethnic Greek school children from Russian immigrant families in Athens. FEMS Immunol Med Microbiol. 1999;23(1):13–20. doi:10.1111/j.1574-695X.1999.tb01711.x.
- Taha M-K, Achtman M, Alonso J-M, Greenwood B, Ramsay M, Fox A, Gray S, Kaczmarski E. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet. 2000;356(9248):2159. doi:10.1016/S0140-6736(00)03502-9.
- Ladhani SN, Beebeejaun K, Lucidarme J, Campbell H, Gray S, Kaczmarski E, Ramsay ME, Borrow R. Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales. Clin Infect Dis. 2015;60(4):578–85. doi:10.1093/cid/ciu881.
- Smith-Palmer A, Oates K, Webster D, Taylor S, Scott KJ, Smith G, Parcell B, Lindstrand A, Wallensten A, Fredlund H, et al. Outbreak of Neisseria meningitidis capsular group W among scouts returning from the World Scout Jamboree, Japan, 2015. Eur Surveill. 2016;21:30392. doi:10.2807/1560-7917.ES.2016.21.45.30392.
- Booy R, Gentile A, Nissen M, Whelan J, Abitbol V. Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies. Hum Vaccin Immunother. 2019;15(2):470–80. doi:10.1080/21645515.2018.1532248.
- Honskus M, Okonji Z, Musilek M, Kozakova J, Krizova P, Berbers GA. Whole genome sequencing of Neisseria meningitidis W isolates from the Czech Republic recovered in 1984–2017. PLoS One. 2018;13(9):e0199652. doi:10.1371/journal.pone.0199652.
- Honskus M, Okonji Z, Musilek M, Krizova P, Lin B. Whole genome sequencing of Neisseria meningitidis Y isolates collected in the Czech Republic in 1993–2018. PloS ONE. 2022;17(3):e0265066. doi:10.1371/journal.pone.0265066.
- Igidbashian S, Bertizzolo L, Tognetto A, Azzari C, Bonanni P, Castiglia P, Conversano M, Esposito S, Gabutti G, Icardi G, et al. Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy. J Prev Med Hyg. 2020;61:E152–e61. doi:10.15167/2421-4248/jpmh2020.61.2.1589.
- Pace D, Gauci C, Barbara C. The epidemiology of invasive meningococcal disease and the utility of vaccination in Malta. Eur J Clin Microbiol Infect Dis. 2020;39(10):1885–97. doi:10.1007/s10096-020-03914-8.
- Taha M-K, Gaudelus J, Deghmane A-E, Caron F. Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries. Hum Vaccin Immunother. 2020;16(10):2518–23. doi:10.1080/21645515.2020.1729030.
- Gruhn S, Witte J, Greiner W, Damm O, Dietzsch M, Kramer R, Knuf M. Epidemiology and economic burden of meningococcal disease in Germany: a systematic review. Vaccine. 2022;40(13):1932–47. doi:10.1016/j.vaccine.2022.02.043.
- World Health Organization. Defeating meningitis by 2030: a global road map. World Health Organization; 2021 [accessed 2023 December 5]. https://apps.who.int/iris/rest/bitstreams/1352955/retrieve
- Burman C, Serra L, Nuttens C, Presa J, Balmer P, York L. Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination. Hum Vac Immunother. 2019;15:459–69. doi:10.1080/21645515.2018.1528831.
- Masaquel C, Schley K, Wright K, Mauskopf J, Parrish RA, Presa JV, Hewlett D Jr. The impact of social determinants of health on meningococcal vaccination awareness, delivery, and coverage in adolescents and young adults in the United States: a systematic review. Vaccines. 2023;11(2):11. doi:10.3390/vaccines11020256.
- Taha MK, Martinon-Torres F, Köllges R, Bonanni P, Safadi MAP, Booy R, Smith V, Garcia S, Bekkat-Berkani R, Abitbol V. Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease. Expert Rev Vaccines. 2022;21(5):659–74. doi:10.1080/14760584.2022.2052048.
- Clark SA, Campbell H, Ribeiro S, Bertran M, Walsh L, Walker A, Willerton L, Lekshmi A, Bai X, Lucidarme J, et al. Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in England. J Infect. 2023;87(5):385–91. doi:10.1016/j.jinf.2023.09.002.